Vivek Ramaswamy’s Plans In the Pipeline, 11 Jan 2017 I last wrote about Vivek Ramaswamy in the context of his first company (Axovant). That one went public on the hopes for a…
Where’s the Real Danger from Infection This Summer? Molecules to Medicine, 27 Aug 2013 Naegleria fowleri…